glp-1 agonist depression Glucagon-like peptide-1 medicines in neurological and psychiatric disorders Mechanisms of GLP-1 Receptor Agonist-Induced
Description
Metseras pipeline includes MET-097i, a GLP-1 receptor agonist designed for once-monthly dosing, and MET-233i, an amylin analog being developed for monthly administration
Therefore, therapeutic options that could work in a way other than classic antidepressants are being sought to increase the effectiveness of the treatment
00014-3/asset/40e31193-0789-44ef-bfbd-d626246a3086/main.assets/gr4_lrg.jpg)
Semaglutide was removed in February 2025
No direct causal link has been established between GLP-1R use and increased aspiration risk
This is the unlikely journey from desert predator to medical marvel.
Week 2+: Regular daily movements, burps gone, sustained energy and mental clarity
